TROP2 expression in non-small cell lung cancer

被引：5
|
作者：
Kuo, Peiwen
Elboudwarej, Emon
Diehl, Lauri
Patel, Jilpa
Mekan, Sabeen
Jurgensmeier, Juliane M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4396
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Significance of EpCAM and TROP2 expression in non-small cell lung cancer
    Pak, Min Gyoung
    Shin, Dong Hoon
    Lee, Chang Hun
    Lee, Min Ki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [2] Significance of EpCAM and TROP2 expression in non-small cell lung cancer
    Min Gyoung Pak
    Dong Hoon Shin
    Chang Hun Lee
    Min Ki Lee
    World Journal of Surgical Oncology, 10
  • [3] TROP2 expression and response to immune checkpoint inhibition in patients with advanced non-small cell lung cancer
    Italiano, Antoine
    Leroy, Laura
    Guegan, Jean-Philippe
    Cousin, Sophie
    Peyraud, Florent
    Cabart, Mathilde
    Chomy, Francois
    Vanhersecke, Lucile
    Bessede, Alban
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Combining immunotherapy with Trop2 ADc in early stage non-small cell lung cancer (CITADEL)
    Li, S. C. M.
    Mok, T. S. K.
    Ng, C.
    Cheung, A. H.
    Chan, S.
    Lee, V. W. K.
    Lim, M. Y. F.
    Chow, J. C-H.
    Cheung, K. M.
    Li, K.
    Liao, G.
    Wong, I. W. C.
    Lee, V. H. F.
    Mok, S. T. F.
    Mok, K.
    Lau, R.
    Chan, J. W. Y.
    Nyaw, S. F.
    ANNALS OF ONCOLOGY, 2024, 35 : S792 - S793
  • [5] The TROP2 paradox: enhancing precision in immunotherapy for advanced non-small cell lung cancer patients-a commentary
    Khan, Saqib Raza
    Verma, Saurav
    Breadner, Daniel
    Raphael, Jacques
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 660 - 666
  • [6] TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer
    Bessede, Alban
    Peyraud, Florent
    Besse, Benjamin
    Cousin, Sophie
    Cabart, Mathilde
    Chomy, Francois
    Rey, Christophe
    Lara, Oren
    Odin, Ophelie
    Nafia, Imane
    Vanhersecke, Lucile
    Barlesi, Fabrice
    Guegan, Jean-Philippe
    Italiano, Antoine
    CLINICAL CANCER RESEARCH, 2024, 30 (04) : 779 - 785
  • [7] Eradicating Drug Tolerant Persisters (DTPs) In EGFRMutated Non Small Cell Lung Cancer (NSCLC) By Targeting TROP2
    Baldacci, S.
    Brea, E. J.
    Facchinetti, F.
    Malhotra, S.
    Tolstorukov, M.
    Booker, M.
    Li, Z.
    Chakravarti, S.
    Lococo, F.
    D'Agnelli, S.
    Gnetti, L.
    Leonetti, A.
    Feng, W. W.
    Tsai, J. A.
    Hartley, A-V
    Locquet, M-A
    Alessi, J. V.
    Awad, M. M.
    Lau, C.
    Saldanha, A.
    Chopade, P.
    Kivlehan, S.
    Ngo, K.
    Lizotte, P.
    Ivanova, E.
    Gokhale, P.
    Paweletz, C.
    Smith, E. L.
    Janne, P. A.
    Barbie, D. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S80 - S80
  • [8] Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma
    Jiang, Aigui
    Gao, Xiaoyan
    Zhang, Degeng
    Zhang, Lixin
    Lu, Huiyu
    ONCOLOGY LETTERS, 2013, 6 (02) : 375 - 380
  • [9] Clinical value of serum trophoblast cell surface protein 2 (TROP2) antibody in non-small-cell lung cancer patients
    Zheng, Zhuan
    Dong, Xue-Jun
    BIOMARKERS, 2016, 21 (08) : 739 - 742
  • [10] MiRNA expression in non-small cell lung cancer
    Petkova, Veronika
    Marinova, Dora
    Kyurkchiyan, Silva
    Stancheva, Gergana
    Mekov, Evgeni
    Kachakova-Yordanova, Darina
    Slavova, Yanina
    Kostadinov, Dimitar
    Mitev, Vanyo
    Kaneva, Radka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 540 - 540
12345